Thyroid Treatment and Vitamin D Update

Preview:

DESCRIPTION

A CPMC Regional CME Event. Thyroid Treatment and Vitamin D Update. - An Integrated Approach. Saturday October 27, 2012. Hypothyroidism. Diana M. Antoniucci, MD, MAS Sutter Pacific Medical Foundation Division of Endocrinology, Diabetes and Osteoporosis Assistant Clinical Professor Medicine - PowerPoint PPT Presentation

Citation preview

THYROID TREATMENT AND VITAMIN D UPDATEA CPMC Regional CME Event

- An Integrated Approach

Saturday October 27, 2012

HYPOTHYROIDISM

Diana M. Antoniucci, MD, MASSutter Pacific Medical Foundation

Division of Endocrinology, Diabetes and OsteoporosisAssistant Clinical Professor Medicine

University of California, San Francisco

IN YOUR OFFICE…

• 56 yo man presents complaining of fatigue and constipation

• His PMHx is significant for coronary artery disease

• What is the best screening test for thyroid disease?

HYPOTHYROIDISM

• 2% of adult women • 0.1-0.2% of adult men

Fatigue

Forgetfulness/Slower ThinkingMoodiness/ Irritability

DepressionInability to ConcentrateThinning Hair/Hair Loss

Loss of Body Hair

Dry, Patchy Skin

Weight GainCold Intolerance

Elevated CholesterolFamily History of Thyroid Disease

or Diabetes 1

Muscle Weakness/Cramps

Constipation

Infertility

Menstrual Irregularities/Heavy Period

Slower HR and low voltage ECGDifficulty Swallowing

Persistent Dry or Sore Throat

Hoarseness/Deepening of Voice

Small or Enlarged Thyroid (Goiter)

Peri-orbital Edema

CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

• Hashimoto’s, or autoimmune thyroiditis – most common

• Drugs: amiodarone, lithium, interferon, iodide

• Iatrogenic: post surgical, post RAI rx or post XRT for neck cancer

• Rare causes: iodine deficiency, central hypothyroidism, peripheral resistance to thyroid hormone.

THYROID TESTS• Thyroid Function Tests (TFTs):

- TSH – good to screen initially- Free T4 – needed to follow patients and to rule out

central thyroid disease- Total or Free T3 – to r/o or r/i T3 thyrotoxicosis only- Thyroglobulin – thyroid cancer or presumed

subacute thyroiditis• Thyroid antibodies

- TPO and Tg Ab’s: sensitive for autoimmune thyroid dz, esp. Hashimoto’s

- TSH rcptr stimulating immunoglobulins (TSI): specific for Graves’ disease

BACK TO OUR CASE…

• His TSH is elevated at 63 uIU/ml (0.4-4.5)

• What other laboratories/studies should you order?

• How could you make a diagnosis of Hashimoto’s?

RESULTS

• His TPO antibodies and TG antibodies are positive

• No need to check ultrasound in this setting

• Thyroglobulin level also not necessary

• Should you treat?• If so with what?

HYPOTHYROIDISM THERAPY

• Standard: synthetic thyroxine (T4)- Little intrinsic activity- Converted to T3 in peripheral tissues- Most physiologic replacement

• Controversy of generics vs brand bioequivalence- 1997 study Synthroid, Levoxyl and 2 generics1

- Used FDA recommended methodology to determine bioequivalence• All 4 preparations were bioequivalent

1Dong BJ et al. JAMA 1997; 277:1205

HYPOTHYROIDISM THERAPY

• Preferable to stay with one formulation when possible (generics – request same manufacturer)

• Levoxyl reportedly easier to absorb than Synthroid

• Tirosint – supposed to be unaffected by concomitant food intake

HYPOTHYROIDISM THERAPY

• Estimated weight based replacement dose:- 1.6 mcg/kg/d

• Dose depends on cause of hypothyroidism and stage of disease- Athyroid patients tend to need higher

doses• Starting dose depends on age, co-

morbidities and TSH

HYPOTHYROIDISM THERAPY

• In young healthy patients, can start full expected dose (1.6 mcg/kg/d)

• Older patients start at 25-50 mcg/d• Goal of therapy

- Symptom amelioration- TSH 1-2 uIU/ml

• Adjust no more often than every 6-8 weeks

• Small adjustments are best: - 12 mcg to at most 25 mcg increments in dose

BACK TO YOUR OFFICE

• 56 yo hypothyroid man with hx of CAD• START LOW AND GO SLOW: Start low doses of

LT4 and slowly increase dose, be particularly careful in patients with heart disease

• Start LT4 12.5-25 mcg po qd. Recheck TFTs in 4-6 weeks and increase dose as needed

• Given his CAD, would start very low, increase every 4 weeks until approaching final expected dose

ANOTHER DAY IN YOUR OFFICE…

• 28 yo woman with long standing hypothyroidism

• On stable replacement dose levothyroxine 112 mcg/d for years

• She reports fatigue, constipation and more irregular cycles

• TSH: 9.5 uIU/ml (0.4-4.5)• Talking to her you discover she added

prenatal vitamins to her regimen…

HOW TO TAKE LEVOTHYROXINE

• Ideally:- 1st thing in AM- Empty stomach- No food for 30 min- Delay any calcium containing foods at

least 1 hr.• Move any iron or calcium containing

supplements to dinner time.

IN THE OFFICE

• She moves prenatal vitamin to dinner time

• 6 weeks later, TSH is back down to 1.2 uIU/ml

• 4 months later, repeat TSH is 3.5 uIU/ml

• What happened?• Pregnancy test is now positive!

HYPOTHYROIDISM IN PREGNANCY

• Requirement of levothyroxine increase 25-50% in pregnancy

• It is common for TSH to rise early on• Recommendations are to maintain TSH <2.5

uIU/ml throughout pregnancy• Check TSH, FT4 and TT4 every 4 weeks in

first 16 weeks and adjust as needed• Management of hypothyroidism in pregnancy

is a very appropriate referral to endocrinology

Journal of Clinical Endocrinology & Metabolism, 97: 2543–2565, 2012).

AND ANOTHER PATIENT…

• 34 yo woman with 5 year history hypothyroidism

• TSH has been between 1-2 uIU/ml (0.4-4.5) for a few yrs

• Reports continued fatigue and not feeling same as before hypothyroidism

• Should you treat her with combination T4 and T3?

HYPOTHYROID PT WITH PERSISTENT SYX

• Symptoms reported:- Fatigue- Diminished concentration and working memory- Poorer psychological well being

• Start with evaluation by PCP:- H&P- Labs: CMP, CBC, ESR, celiac dz testing, sleep apnea

screening or testing• Then Endo evaluation:

- 25OHD- Adrenal evaluation

• Consider possibility of depression

TREATMENT WITH COMBINATION THERAPY

• Multiple randomized trials• Systematic review of 11 randomized trials

- One trial (n=35): beneficial effects on mood, quality of life and psychometric performance of T4-T3 combo vs T4 alone

- Remainder failed to show benefit• Subanalysis in one study1 homozygous

polymorphisms in a deiodinase (in 16% people)- Worse baseline neuro-cognitive scores- Significant improvement with combo T4/T3 rx

1Panicker V et al J Clin Endocrinol Metab 2009; 94: 1623

TREATMENT WITH COMBINATION THERAPY

• Not necessary• Up to 16% hypothyroid patients may

benefit• No genetic test available now• Trial in still symptomatic patients is

reasonable- T4:T3 ratio of 10:1 to 14:1- Typically 2.5-5 mcg liothyronine qd to bid

added to T4- Goals of therapy same

T3 CONTAINING PREPARATIONS

• Include desiccated thyroid (Armour), T4-T3 preparations (Thyrolar, Naturethroid)

• Wide fluctuations in serum T3 concentrations• Often unavailable due to manufacturing issues• T4/T3 Ratio is not physiological• No clear benefit and more difficult to dose and

adjust • Consider referral for convertion to T4 or T4+T3• Avoid in pregnancy

PEARLS

• TSH best screening test• No need to order Tg or ultrasound in patients with

hypothyroidism• Always review how patients are taking LT4 pills• Aim for TSH 1-2• If still symptomatic, consider T3 addition• Sensitivity to TSH changes and how much TSH changes in

response to dose changes are somewhat variable• Refer if:

- Pregnancy- Worried about co-morbidities- TSH is not responding as expected- Patients still fatigued even at goal TSH and other causes of fatigue ruled

out

Recommended